BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stratedigm Announces the Commercial Launch of Its Most Advanced Flow Cytometer Platform to Date; the 18 Color 4 Laser S1000EXi


9/18/2013 9:57:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN JOSE, Calif.--(BUSINESS WIRE)--Stratedigm announced the commercial launch of its S1000EXi flow cytometers on August 28, 2013. The “EXi” model offers Stratedigm’s most advanced technology to date and sets a new gold standard for high performance, benchtop analyzers. Architected based on the revolutionary EX model, the S1000EXi incorporates newly developed, patent pending second-generation Smart Detect™ and Laser Trimming™ technologies, enabling the detection of up to 18 colors with 4 lasers and unmatched dynamic range for low threshold and microparticle applications. The S1000EXi model also offers seamless integration with the industry’s most versatile and powerful high throughput automation line. “The S1000EXi embodies the culmination of a decade of patented and patent pending research in advanced optics, electronics, and fluidics in a compact and easy to use flow cytometer. Moving forward, Stratedigm plans to standardize all of it analyzers, including its entry-level models with its revolutionary second-generation Smart Detect™ technology. The S1000EXi model is available as an upgrade to all legacy S1000 instruments,” noted Shervin Javadi, Stratedigm’s chief executive officer.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES